You are here

Study Recruitment: Treatment of Disturbed Sleep in PSP

Study Recruitment: Treatment of Disturbed Sleep in PSP

Treat-disturbed-sleep-PSP.png

This remote six-week study seeks to test the effects of two sleep medications.

This remote six-week study seeks to test the effects of two sleep medications.

You, or a family member, may fit the general eligibility criteria for the research study listed below. Please note:

  • This information is provided to make you aware of the study, and help direct you to where to find more information.
  • This email is not a specific endorsement of whether you should or should not consider participating in the study.
  • With any research study, you should carefully read the study description, contact the study coordinator for more information, and talk through any issues with your family and clinician(s) as appropriate.

Study Overview

This study is a remote, crossover design (everyone will receive two specific FDA approved sleeping medications and a placebo) clinical trial being run by Dr. Thomas Neylan at the University of California, San Francisco. It aims to test the effect of two sleep medications on the treatment of sleep disruption in Progressive Supranuclear Palsy (PSP) without the need of in-person visits to a study site.

Participants need to have a diagnosis of PSP and be based in California.  

All participants will need a care partner who can help provide information about the patient during the interviews.

All standard study assessments will be done over the phone. The study lasts for six weeks, with at least one phone call every week. 

Contact Information

For more information, please contact the study team:

Visit the study's website for more information and to see if you qualify.

Disturbed Sleep in PSP Study

Visit the FTD Disorders Registry Find A Study webpage for information on this and other study listings.

FIND A STUDY